Borrowing using historical-bias power prior with empirical Bayes

HY Lin, E Slate - Journal of Biopharmaceutical Statistics, 2024 - Taylor & Francis
Adaptively incorporating historical information into analyses of current data can improve the
precision of inference without requiring additional new observation. Unfortunately, not all …

Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint

H Quan, Z Xu, J Luo, G Paux, M Cho… - Pharmaceutical …, 2023 - Wiley Online Library
To design a phase III study with a final endpoint and calculate the required sample size for
the desired probability of success, we need a good estimate of the treatment effect on the …

Integration of Efficacy Biomarkers Together with Toxicity Endpoints in Immune-Oncology Dose Finding Studies

Y Zhang, Z Xu, H Quan, J Lin - arXiv preprint arXiv:2302.04777, 2023 - arxiv.org
The primary objective of phase I oncology studies is to establish the safety profile of a new
treatment and determine the maximum tolerated dose (MTD). This is motivated by the …